Dillon Gasper

Real world data presented by @krchhabra group at #ASMBS2025 Weight loss after 2 years: ✴️ Gastric bypass: 26% ✴️ Sleeve gastrectomy: 23% ✴️ Tirzepatide: 8% ✴️ Semaglutide: 5%

From one of my upcoming lectures: ~90% of people living with obesity remain untreated.

@EzraTeitelbaum I counted 9 but one or two could be due to slow filling of duodenum. Would try glucagon and another power flush. 68 looks like a diverticulum possibly type III

Challenge for all cholangiogram-ers out there! Here are 72 IOCs I did in the last year. 🏆1st Prize🏆 goes to whoever can correctly identify most CBD stones. Bonus points for finding any other anatomic/other abnormalities...

AI Ambient listening! @npetcka2022 @EmoryUniversity @EdLinEmory @VNikolian @EricKnauerMD

@htjacks Congratulations! Your patients are fortunate to have you

SO excited for this opportunity!!! #GoBlue #PaulettesDaughter 👇🏾

🏆 Tirzepatide vs. Semaglutide The heavyweight bout we’ve all been waiting for—and it’s a TKO. - - - A new NEJM study just dropped the first head-to-head trial in people with obesity (no diabetes). Here’s how it played out over 72 weeks: 🥇 Tirzepatide (Zepbound) vs 🥈 Semaglutide (Wegovy) 🔹 –20.2% vs –13.7% weight loss → 47% greater relative reduction 🔹 20% on tirzepatide lost ≥30% of their body weight (triple the semaglutide rate!) 🔹 Waistline: –18.4 cm vs –13.0 cm 🔹 Sex matters: women in both arms lost ~6% more than men 📉 Responder rates (tirzepatide vs semaglutide): ✅ ≥10% loss: 81.6% vs 60.5% ✅ ≥15% loss: 64.6% vs 40.1% ✅ ≥20% loss: 48.4% vs 27.3% ✅ ≥25% loss: 31.6% vs 16.1% ⚠️ Side effects? Mostly GI. Mostly manageable. No new red flags. Bottom line: This isn’t incremental—it’s transformational. GLP-1 was the revolution. Tirzepatide is the next frontier. Let’s talk: Access. Equity. Long-term outcomes. Are formularies ready for this future? 🔗 Full NEJM study: nejm.org/doi/full/10.10… #Zepbound #Wegovy #Tirzepatide #Semaglutide #ObesityMedicine #GLP1 #GIP #NEJM #WeightLoss #HealthTech #DigitalHealth #MedTwitter h/t @scottisaacsmd for images.

POV You’re a med student driving the lap scope for the first time Your attending: “The horizon still isn't straight” You *panics in sunset 🌇🌇* This @BehindTheKnife video might help 👇

@SrineilV Congratulations 🎉

Entering my Christina Yang era 🫶🏻😭🎉 #thoracicsurgery #fellowshipmatch

ENDOSURGERY #2: ENDOBARIATRICS Did you know you can do a sleeve with an endoscope? How cool is that 🕶️??! Find out if it is all it's cracked up to be + watch some great footage 📹 👇🏼 app.behindtheknife.org/podcast/surgic… Great work from our endosurgery team @SAyusoMD @CraftsTrevor @UjikiMike @briandunkinmd

🧵 IS BARIATRIC SURGERY DANGEROUS? Let’s look at the global data. Swipe through for a data-driven breakdown.

Great talk by Dr. Matthew Ballweg this morning on the role of hand assisted MIS techniques for elective #diverticulitis with lower rates of ostomy formation and decreased operating time #SWSC25 #MIS

Great talk on robotic surgery and MIS techniques increased utilization in emergency general surgery by Dr. Anderson #Roboticsurgery #EGS

Had the greatest team and we preserved through adversity. Thanks for the great weekend!

Great talk at the SAGES fellows course by @htjacks on social media

Let the ⁦@SAGES_Updates⁩ 6th annual Fellows Career Development Course begin!!! ⁦@IvyNHaskinsMD⁩

Having an awesome time at the annual SAGES MIS Fellows' Course in Nashville! Talented group of fellows and incredible Faculty--

The Arizona crew is learning a lot and having a great time at @ASMBS #asmbs2024 @UofAZSurgery @ImanGhaderi @SarahSohail89 @DillonGasper

Difference of Bariatric surgery versus medical management for prevention of diabetes in patients with obesity (15 year follow up) @LdePinaCV great work 👏🏽

Inspiring to hear the work of Hall of Fame inductees and the innovative work to bring metabolic surgery from the fringe to help patients with obesity

Excited to hear the latest evidence from the experts in Bariatric and Metabolic Surgery @ASMBS